
NYSEHealthcareMedical - Devices
ข้อมูลล่าสุด
US$126.64
−US$0.01 · -0.01%
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
ช่วงเวลาซื้อขายปกติ
US$126.67
+US$0.02 · +0.02%
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
ช่วงราคารายวัน
ปัจจุบัน US$126.67
ช่วง 52 สัปดาห์
ปัจจุบัน US$126.67
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
คะแนน GoAI
ซื้อ
มูลค่า
92
มูลค่าน่าสนใจมาก
ความเชื่อมั่น
68
เชิงบวก
ความเสี่ยง
30
ความเสี่ยงปานกลาง
โมเมนตัม
46
เป็นกลาง
งานวิจัย GoAI ฉบับเต็ม
ดูข้อมูลสนับสนุน ปัจจัยหนุน และความเสี่ยงในเชิงลึก
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
ช่วงราคารายวัน
ปัจจุบัน US$126.67
ช่วง 52 สัปดาห์
ปัจจุบัน US$126.67
อัตรากำไรที่รายงานในช่วงเวลาที่มีอยู่
รายได้
รายได้จากการดำเนินงาน
รายได้สุทธิ
| รายการ (USD) | ปีงบประมาณ 2025 | ปีงบประมาณ 2024 | ปีงบประมาณ 2023 | ปีงบประมาณ 2022 | ปีงบประมาณ 2021 |
|---|---|---|---|---|---|
| รายได้ | 1.85B USD | 1.72B USD | 1.56B USD | 1.33B USD | 1.22B USD |
| ต้นทุนสินค้าขาย | 1.42B USD | 1.26B USD | 1.14B USD | 984.63M USD | 884.11M USD |
| กำไรขั้นต้น | 425.81M USD | 461.18M USD | 411.52M USD | 346.65M USD | 336.97M USD |
| การวิจัยและพัฒนา | 46.35M USD | 53.43M USD | 61.97M USD | 59.76M USD | 51.99M USD |
| การขาย ทั่วไป และธุรการ | 162.59M USD | 184.33M USD | 171.47M USD | 157.36M USD | 141.69M USD |
| ค่าใช้จ่ายในการดำเนินงาน | 216.55M USD | 252.95M USD | 248.2M USD | 233.97M USD | 201.26M USD |
| ดอกเบี้ยจ่าย | 42.31M USD | 56.37M USD | 53.37M USD | 37.27M USD | 31.63M USD |
| ค่าเสื่อมราคาและค่าตัดจำหน่าย | 130.67M USD | 111.03M USD | 98.84M USD | 91.99M USD | 81.37M USD |
| รายได้จากการดำเนินงาน | 209.27M USD | 208.24M USD | 163.32M USD | 112.68M USD | 135.71M USD |
| รายได้สุทธิ | 102.76M USD | 119.9M USD | 90.65M USD | 66.38M USD | 96.81M USD |
ข้อเท็จจริงของบริษัทได้รับการปรับปรุง 9 ต.ค. 2569.
ผลที่ประกาศแล้วพร้อมประมาณการร่วมที่มีอยู่
ผลที่ประกาศแล้วพร้อมประมาณการร่วมที่มีอยู่
ประมาณการของนักวิเคราะห์ภายนอกอาจเปลี่ยนแปลงและไม่ใช่คำแนะนำของ GoAI
กองทุนซื้อขายแลกเปลี่ยนที่รายงานความเสี่ยงต่อหุ้นนี้
Vanguard Morningstar Total Stock Market ETFVTI135.63M0.01%2.3T USD0.03%US$382.25+0.71%
iShares Russell 2000 ETFIWM114.4M0.15%77.7B USD0.19%US$279.33+0.63%
Vanguard Morningstar Small-Cap ETFVB97.76M0.05%185.3B USD0.03%US$289.86+0.77%
Vanguard Morningstar Small-Cap Value ETFVBR62.14M0.09%68.2B USD0.05%US$234.78+0.37%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV49.85M0.19%26.91B USD0.33%US$38.015-0.22%
Vanguard Extended Market ETFVXF49.43M0.05%95.4B USD0.05%US$235.21+0.89%
iShares Russell 2000 Value ETFIWN40.39M0.29%13.75B USD0.24%US$211.21+0.12%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM39.6M0.25%15.8B USD0.03%US$53.525+0.31%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Morningstar Small-Cap ETFVB
Vanguard Morningstar Small-Cap Value ETFVBR
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
iShares Russell 2000 Value ETFIWN
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSMเนื้อหาที่สร้างโดย AI และข้อมูลตลาดที่ล่าช้ามีไว้เพื่อให้ข้อมูลและการศึกษาเท่านั้น ไม่ใช่คำแนะนำการลงทุน